CASE UPDATE — MAY 4, 2026: The U.S. Supreme Court entered a temporary, one-week administrative stay, pausing the Fifth Circuit’s May 1 decision which imposed a medically unnecessary, nationwide in-person dispensing requirement for mifepristone. The one-week pause allows justices to consider whether to block the Fifth Circuit’s ruling while the litigation proceeds. If the Supreme...